Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Hepatitis

Free Subscription Articles published in Gut Retrieve available abstracts of 61 articles: HTML format Text format

Single Articles

May 2012
1. GLEESON D , Heneghan MA
   Response letter to 'role of thiopurine metabolite measurement in the management of autoimmune hepatitis'
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. AL-SHAMMA S , McLaughlin S, McCrudden R, Weaver S, et al
   Role of thiopurine metabolite measurement in the management of autoimmune hepatitis.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
3. DANDRI M , Locarnini S
   New insight in the pathobiology of hepatitis B virus infection.
   Gut. 2012;61 Suppl 1:i6-i17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. MUTIMER DJ , Lok A
   Management of HBV- and HCV-induced end stage liver disease.
   Gut. 2012;61 Suppl 1:i59-i67.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LACOMBE K , Rockstroh J
   HIV and viral hepatitis coinfections: advances and challenges.
   Gut. 2012;61 Suppl 1:i47-i58.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WELSCH C , Jesudian A, Zeuzem S, Jacobson I, et al
   New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
   Gut. 2012;61 Suppl 1:i36-i46.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PLOSS A , Dubuisson J
   New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets.
   Gut. 2012;61 Suppl 1:i25-i35.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. LAMPERTICO P , Liaw YF
   New perspectives in the therapy of chronic hepatitis B.
   Gut. 2012;61 Suppl 1:i18-i24.
   PubMed     Text format     Related articles   
   
   
   
   
9. THOMAS D , Zoulim F
   New challenges in viral hepatitis.
   Gut. 2012;61 Suppl 1:i1-i5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
10. ZOUTENDIJK R , Reijnders JG, Zoulim F, Brown A, et al
    Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.
    Gut. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
11. SERFATY L , Forns X, Goeser T, Ferenci P, et al
    Insulin resistance and response to telaprevir plus peginterferon alpha and ribavirin in treatment-naive patients infected with HCV genotype 1.
    Gut. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ZOULIM F , Mason WS
    Reasons to consider earlier treatment of chronic HBV infections.
    Gut. 2012;61:333-6.
    PubMed     Text format     Related articles   
    
    
    
    February 2012
13. ANTAKI N , Bibert S, Kebbewar K, Asaad F, et al
    IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.
    Gut. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
14. MISSALE G , Pilli M, Zerbini A, Penna A, et al
    Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Gut. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HUMPHREYS IS , von Delft A, Brown A, Hibbert L, et al
    HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
    Gut. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
16. CANDOTTI D , Lin CK, Belkhiri D, Sakuldamrongpanich T, et al
    Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.
    Gut. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
17. JANSSEN HL , Sonneveld MJ, Brunetto MR
    Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
18. BERTOLETTI A , Ferrari C
    Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
19. HALAC U , Beland K, Lapierre P, Patey N, et al
    Chronic hepatitis E infection in children with liver transplantation.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. FALLOT G , Halgand B, Garnier E, Branger M, et al
    Recombination of hepatitis B virus DNA in patients with HIV.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. TAMADA Y , Yatsuhashi H, Masaki N, Nakamuta M, et al
    Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. OP DE BEECK K , Van den Bergh K, Vermeire S, Decock S, et al
    Immune reactivity to beta-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders.
    Gut. 2011;60:1601-2.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
23. DEUFFIC-BURBAN S , Mathurin P, Pol S, Larsen C, et al
    Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. KELLY C , Klenerman P, Barnes E
    Interferon lambdas: the next cytokine storm.
    Gut. 2011;60:1284-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
25. KLENERMAN P , Thimme R
    T cell responses in hepatitis C: the good, the bad and the unconventional.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. THOMPSON AJ , Patel K, Chuang WL, Lawitz EJ, et al
    Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. BRENNDORFER ED , Brass A, Soderholm J, Frelin L, et al
    Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-{gamma} production.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
28. GLEESON D , Heneghan MA
    British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
29. FITZMAURICE K , Petrovic D, Ramamurthy N, Simmons R, et al
    Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
30. THURSZ M , Brown A
    Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
31. CARDOSO AC , Carvalho-Filho RJ, Marcellin P
    Transient elastography in chronic viral hepatitis: a critical appraisal.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. MELGAR-LESMES P , Pauta M, Reichenbach V, Casals G, et al
    Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
33. LIU F , Chen L, Yu DM, Deng L, et al
    Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MUTIMER D
    Tenofovir salvage for nucleoside experienced patients: muddy waters?
    Gut. 2011;60:148-50.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
35. PAPATHEODORIDIS GV , Manolakopoulos S, Touloumi G, Vourli G, et al
    Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET.Greec
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MIQUILENA-COLINA ME , Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, et al
    Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. EL-SERAG HB , Kramer JR, Chen GJ, Duan Z, et al
    Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ESLAM M , Khattab MA, Harrison SA
    Insulin resistance and hepatitis C: an evolving story.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
39. DI MARCO V , Calvaruso V, Iaco A, Bronte F, et al
    Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
40. THOMSON EC , Fleming VM, Main J, Klenerman P, et al
    Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
41. HAYES CN , Kobayashi M, Akuta N, Suzuki F, et al
    HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. LEE MH , Yang HI, Jen CL, Lu SN, et al
    Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991-2.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. PAEZ JIMENEZ A , Sharaf Eldin N, Rimlinger F, El-Daly M, et al
    HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt.
    Gut. 2010;59:1554-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
44. PATTERSON SJ , George J, Strasser SI, Lee AU, et al
    Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HUANG HH , Shih WL, Li YH, Wu CF, et al
    Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon {gamma} signalling pathway.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. PATEL H , Heathcote EJ
    Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
47. SVEGLIATI-BARONI G , Faraci G, Fabris L, Saccomanno S, et al
    Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. BARDOU-JACQUET E , Lorho R, Guyader D
    Kinase inhibitors in the treatment of chronic hepatitis C virus.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
49. MATHURIN P , O'Grady J, Carithers RL, Phillips M, et al
    Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. BRIDGE SH , Sheridan DA, Felmlee DJ, Nielsen SU, et al
    Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. MANCONE C , Steindler C, Santangelo L, Simonte G, et al
    Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. ZHOU H , Huang H, Shi J, Zhao Y, et al
    Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. NEGRO F
    Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
54. BOKEMEYER M , Ding XQ, Goldbecker A, Raab P, et al
    Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BEAUGERIE L , Gerbes AL
    Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?
    Gut. 2010;59:1310-1.
    PubMed     Text format     Related articles   
    
    
    
    
56. STEPANOVA M , Rafiq N, Younossi ZM
    Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Gut. 2010;59:1410-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. WURSTHORN K , Wedemeyer H, Manns MP
    Managing HBV in patients with impaired immunity.
    Gut. 2010;59:1430-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
58. CHEENT K , Khakoo SI
    Natural killer cells and hepatitis C: action and reaction.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MAO Y , Yang H, Xu H, Lu X, et al
    Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. MOUCARI R , Forestier N, Larrey D, Guyader D, et al
    Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
61. LORENZINI S , Bird TG, Boulter L, Bellamy C, et al
    Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.
    Gut. 2010;59:645-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: